Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis Presenting as Acute Psychosis and Seizures in a Patient With Multiple Sclerosis: A Diagnostic Challenge.

Created on 11 Jul 2026

Authors

Alireza Izadian Bidgoli, Yaroslav Buryk, Amanda Pina

Published in

Cureus. Volume 18. Issue 6. Pages e110612. Epub Jun 10, 2026.

Abstract

Autoimmune encephalitis (AE) is a potentially reversible cause of acute neuropsychiatric deterioration; however, diagnosis may be delayed when symptoms overlap with those of pre-existing neurologic disorders. We report the case of a 27-year-old woman with known multiple sclerosis (MS) who presented with acute psychosis and rapidly progressed to focal seizures, encephalopathy, catatonia, dyskinesias, and autonomic instability. Initial neuroimaging demonstrated no evidence of active demyelination or other acute intracranial pathology, raising diagnostic uncertainty regarding atypical MS relapse, infectious encephalitis, and other inflammatory processes. Cerebrospinal fluid (CSF) analysis revealed marked lymphocytic pleocytosis, while extensive infectious studies were negative. Electroencephalography demonstrated focal seizure activity arising from the left frontal region, followed by diffuse slowing with superimposed beta activity suggestive of a delta brush-like pattern. Given the characteristic clinical progression and inflammatory CSF findings, AE was strongly suspected, and immunotherapy with high-dose corticosteroids and plasma exchange was initiated before diagnostic confirmation. The diagnosis was ultimately established by positive anti-N-methyl-D-aspartate (NMDA) receptor antibodies in both CSF and serum. This case highlights the importance of recognizing clinical features atypical for MS relapse, including acute psychosis, seizures, and rapidly progressive encephalopathy, and underscores the risk of diagnostic anchoring in patients with established neurologic disease. Early recognition of anti-NMDA receptor encephalitis and prompt initiation of immunotherapy remain critical to optimizing outcomes in this potentially reversible condition.

PMID:
42434672
Bibliographic data and abstract were imported from PubMed on 11 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement